This collaboration will facilitate cross-referrals and contribute to the development of advanced clinical services in OUE Healthcare's Changshu Hospital

OUE Healthcare, the healthcare subsidiary of OUE Limited, announced that its joint venture hospital with the China Merchants Group, Changshu China Merchants – Lippo Obstetrics & Gynaecology Hospital (Changshu Hospital) in Changshu, Jiangsu Province, China, signed a strategic partnership agreement with Zhongda Hospital Southeast University, a renowned public Grade 3A General Hospital in Nanjing, Jiangsu Province, China.

Following the strategic partnership formed with Shanghai Changzheng Hospital, this collaboration marks another milestone for Changshu Hospital to integrate with top-tier public healthcare resources in delivering clinical excellence for its patients.

Changshu Hospital is the first and only private Obstetrics and Gynaecology (O&G) hospital in Changshu city, which provides premium obstetrics, gynaecology, paediatric and other related medical services. Zhongda Hospital is renowned for its critical care medicine, image guided intervention services (minimally invasive surgeries) and integrated medicine.

This strategic partnership encompasses collaboration across various areas, including scientific research, education, nursing, continuing education and management. Specifically, it will establish a two-way green channel for patient access between Zhongda Hospital and Changshu Hospital, facilitate cross-referrals and contribute to the development of advanced clinical services in Changshu Hospital.

Stephen Riady, executive chairman and group CEO of OUE says: “This collaboration will enhance Changshu Hospital’s medical service offerings, and provide Changshu residents with more accessible and higher quality healthcare services.”

Yet Kum Meng, CEO of OUE Healthcare says: “By integrating Zhongda Hospital's cutting-edge medical expertise and Singapore’s patient care framework, we are committed to supporting Changshu Hospital in delivering sustainable, patient-centred healthcare services that align with China’s healthcare reform priorities.”

Shares in OUE closed at $1.00 on Feb 5.